TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.

Emmanuel F Petricoin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.